HomeRGC • NASDAQ
Follow
Regencell Bioscience Holdings Ltd
Previous close
$3.85
Day range
$3.70 - $4.05
Year range
$3.16 - $31.30
Market cap
48.28M USD
Avg Volume
6.05K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 1.42M | -28.16% |
Net income | -1.32M | 31.41% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.35M | 30.54% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 11.56M | -29.56% |
Total assets | 12.62M | -29.95% |
Total liabilities | 632.32K | -32.59% |
Total equity | 11.99M | — |
Shares outstanding | 13.01M | — |
Price to book | 4.18 | — |
Return on assets | -28.17% | — |
Return on capital | -28.55% | — |
Cash Flow
Net change in cash
(USD) | Jun 2023info | Y/Y change |
---|---|---|
Net income | -1.32M | 31.41% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2014
Website
Employees
12